Allergan raised its sales by 9.8 percent to $380.3 million in the 4th quarter ended Dec. 31. In constant currencies, sales would have risen by 14 percent. In constant currencies and exclusing sales of certain skin care products that were divested or licensed out in the 1st half of 1999, ...
Already an Eyewear Intelligence subscriber? Sign in here.
Buying a membership today will give you:
Or sign-up for a trial month for just 9,90€. To continue reading this article register now.